Caspofungin
| Effect of ECMO | Conflicting data on CS. Generally minimal effects on PK, but large inter-subject variability. |
|---|---|
| Dose recommendation | Consider increase in dose |
| Comments, reference | Conflicting data with favorable safety profile support dose increase, e.g., 70 mg q24h (Crit Care 2024;28:326). |